Savara Inc. $SVRA Shares Bought by Vestal Point Capital LP

Key Points

• Vestal Point Capital LP increased its stake in Savara Inc. by 2.1%, now holding 11 million shares and making up about 2.2% of its portfolio.
• Director Richard J. Hawkins purchased 48,225 shares of Savara, increasing his ownership by 71.72%, following a recent acquisition at $2.04 per share.
• Savara received mixed analyst ratings, with price targets ranging from $2.00 to $8.00 after recent earnings missed consensus estimates.

Vestal Point Capital LP boosted its position in shares of Savara Inc. (NASDAQ:SVRA - Free Report) by 2.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,000,000 shares of the company's stock after acquiring an additional 225,000 shares during the period. Savara accounts for 2.2% of Vestal Point Capital LP's holdings, making the stock its 17th biggest position. Vestal Point Capital LP owned 6.37% of Savara worth $30,470,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Savara by 24.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 156,983 shares of the company's stock valued at $482,000 after acquiring an additional 31,168 shares during the last quarter. Millennium Management LLC raised its holdings in shares of Savara by 71.8% in the fourth quarter. Millennium Management LLC now owns 482,263 shares of the company's stock worth $1,481,000 after buying an additional 201,599 shares during the last quarter. Deutsche Bank AG raised its holdings in shares of Savara by 6.1% in the fourth quarter. Deutsche Bank AG now owns 927,595 shares of the company's stock worth $2,848,000 after buying an additional 53,054 shares during the last quarter. D. E. Shaw & Co. Inc. raised its holdings in shares of Savara by 314.7% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 70,560 shares of the company's stock worth $217,000 after buying an additional 53,547 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in shares of Savara by 25.3% in the first quarter. Farther Finance Advisors LLC now owns 32,314 shares of the company's stock worth $92,000 after buying an additional 6,532 shares during the last quarter. Hedge funds and other institutional investors own 87.93% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Oppenheimer raised their price target on shares of Savara from $5.00 to $6.00 and gave the stock an "outperform" rating in a report on Friday, August 15th. Wells Fargo & Company decreased their price target on shares of Savara from $8.00 to $7.00 and set an "overweight" rating for the company in a report on Wednesday, May 28th. Guggenheim reaffirmed a "buy" rating and issued a $8.00 price target (down previously from $9.00) on shares of Savara in a report on Wednesday, May 28th. HC Wainwright raised their price target on shares of Savara from $5.00 to $8.00 and gave the stock a "buy" rating in a report on Wednesday. Finally, Evercore ISI decreased their price target on shares of Savara from $3.00 to $2.00 and set an "in-line" rating for the company in a report on Wednesday, May 28th. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $6.67.

Savara Stock Performance

Shares of Savara stock traded up $0.16 during trading on Thursday, hitting $3.58. 1,775,465 shares of the company's stock were exchanged, compared to its average volume of 1,613,274. The company has a debt-to-equity ratio of 0.25, a quick ratio of 11.08 and a current ratio of 11.08. The business has a 50-day simple moving average of $2.68 and a 200-day simple moving average of $2.70. Savara Inc. has a 52-week low of $1.89 and a 52-week high of $4.70. The stock has a market capitalization of $618.77 million, a price-to-earnings ratio of -7.16 and a beta of 0.56.

Savara (NASDAQ:SVRA - Get Free Report) last issued its earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.02). On average, research analysts forecast that Savara Inc. will post -0.45 EPS for the current year.

Insider Activity

In other news, Director Richard J. Hawkins purchased 48,225 shares of the company's stock in a transaction that occurred on Friday, June 20th. The shares were bought at an average price of $2.04 per share, for a total transaction of $98,379.00. Following the completion of the transaction, the director owned 115,466 shares in the company, valued at $235,550.64. This represents a 71.72% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 5.33% of the stock is currently owned by company insiders.

Savara Profile

Savara Inc, formerly Mast Therapeutics, Inc, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients.